新たに診断した癲癇または再発性癲癇のラモトリジン単剤療法:多施設非盲検スタディ

YAMAMOTO Takamichi; HONG Seung Bong; SHIMIZU Masahiro; SATO Katsuaki; NUMACHI Yotaro

文献

J-GLOBAL ID：201402244245838741 整理番号：14A1012738

新たに診断した癲癇または再発性癲癇のラモトリジン単剤療法:多施設非盲検スタディ

Lamotrigine monotherapy in newly diagnosed epilepsy or recurrent epilepsy:A multi-center, open-label study

出版者サイト {{ this.onShowPLink() }} 複写サービスで全文入手 {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=14A1012738&COPY=1") }}
高度な検索・分析はJDreamⅢで {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A1012738&from=J-GLOBAL&jstjournalNo=U0078A") }}

著者 (5件)： , , , ,
資料名：
巻： 7 号： 1 ページ： 55-65 (J-STAGE) 発行年： 2014年
JST資料番号： U0078A ISSN： 1882-5567 資料種別：逐次刊行物 (A)
記事区分：原著論文発行国：日本 (JPN) 言語：英語 (EN)

目的:第2に全身性発作または全身性強直・間代発作を含む新たに...

,...
,...

続きはJDreamIII（有料）にて {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A1012738&from=J-GLOBAL&jstjournalNo=U0078A") }}

神経系疾患の薬物療法 , 抗てんかん薬・抗けいれん薬の臨床への応用

引用文献 (12件)：

[1] Karceski S, Morrell MJ, Carpenter D. Treatment of epilepsy in adults: expert opinion, 2005. Epilepsy Behav 2005; Suppl 1: S1-S64
[2] National Institute for Health and Clinical Excellence (NICE). The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. NICE clinical guideline CG137 2012. Available at URL(2013.12): http://www.nice.org.uk/cg137
[3] Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJL, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Shackley P, Shen J, Smith DF, Smith PEM, Smith CT, Vanoli A, Williamson PR, on behalf of the SANAD Study group. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomized controlled trial. Lancet 2007; 369: 1000- 1015
[4] Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJL, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Shackley P, Shen J, Smith DF, Smith PEM, Smith CT, a Vanoli A, Williamson PR, on behalf of the SANAD Study group. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalized and unclassifiable epilepsy: an unblinded randomized controlled trial. Lancet 2007;369:1016-1026
[5] Brodie MJ, Richens A, Yuen AWC, for UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995;345:476-479

, , , , , , ,

前のページに戻る